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ABSTRACT
Aim This study models the cost-effectiveness of brief
advice (BA) in primary care for physical activity (PA)
addressing the limitations in the current limited
economic literature through the use of a time-based
modelling approach.
Methods A Markov model was used to compare the
lifetime costs and outcomes of a cohort of 100 000
people exposed to BA versus usual care. Health
outcomes were expressed in terms of quality-adjusted
life years (QALYs). Costs were assessed from a health
provider perspective (£2010/11 prices). Data to populate
the model were derived from systematic literature reviews
and the literature searches of economic evaluations that
were conducted for national guidelines. Deterministic
and probability sensitivity analyses explored the
uncertainty in parameter estimates including short-term
mental health gains associated with PA.
Results Compared with usual care, BA is more
expensive, incurring additional costs of £806 809 but it
is more effective leading to 466 QALYs gained in the
total cohort, a QALY gain of 0.0047/person. The
incremental cost per QALY of BA is £1730 (including
mental health gains) and thus can be considered cost-
effective at a threshold of £20 000/QALY. Most changes
in assumptions resulted in the incremental cost-
effectiveness ratio (ICER) falling at or below £12 000/
QALY gained. However, when short-term mental health
gains were excluded the ICER was £27 000/QALY
gained. The probabilistic sensitivity analysis showed that,
at a threshold of £20 000/QALY, there was a 99.9%
chance that BA would be cost-effective.
Conclusions BA is a cost-effective way to improve PA
among adults, provided short-term mental health gains
are considered. Further research is required to provide
more accurate evidence on factors contributing to the
cost-effectiveness of BA.
INTRODUCTION
The positive association between inactive lifestyle
and morbidity and mortality is well documented.1 2
However, only 3 of 10 individuals in England
undertake a level of activity that is sufﬁcient to
meet the recommended levels of physical activity
(PA), as deﬁned by the national guidance.3 In
England, the National Institute for Health and
Care Excellence (NICE) has recommended brief
advice (BA) in primary care as an effective way of
increasing PA in adults.4–6 The US Preventive
Services Task Force recommends that clinicians
counsel adults to engage in PA for prevention of
cardiovascular disease (CVD).7 The European
Union’s PA guidelines recognise the important role
the primary care physicians can play in encouraging
patients to engage in PA.8 BA includes verbal
advice, discussion, negotiation or encouragement,
with or without written or other support or
follow-up. It could be opportunistic and can typic-
ally take from less than a minute to up to 20 min.
To date, BA has not been adequately implemented,
which might be partially attributed to the rather
inadequate effectiveness evidence base.9
Orrow et al10 recently conducted a systematic
review and meta-analysis of the effectiveness of PA
promotion based in primary care. They concluded
that encouraging PA in primary care settings leads
to improved levels of PA and that intensive inter-
ventions do not necessarily lead to better outcomes
than brief interventions. The scope of this review
was, however, relatively narrow as they focused
only on RCTs with a minimum follow-up of
12 months. Therefore, to assist the update of guid-
ance in this area, the NICE recently commissioned
a systematic review and meta-analysis of BA. This
review undertaken by Campbell et al11 had a
broader perspective as they included all available
evidence, RCTs and non-RCTs without limitations
on follow-up time. Campbell et al11 found that at
1 year BA is correlated with a higher probability of
being physically active, although this result did not
quite reach the 5% signiﬁcance level (relative risk
(RR): 1.42; 95% CI 0.98 to 2.06). The addition of
further elements to support BA yielded no statistic-
ally signiﬁcant beneﬁt.
In this paper, this current effectiveness evidence is
used to conduct cost-effectiveness analysis in an area
where there is little economic evidence to inform
resource allocation.12 A recent systematic literature
review13 identiﬁed only three economic evaluations
of BA (one model-based,5 one trial-based14 and one
audit-based analysis15). Pringle et al14 did not report
on the cost-effectiveness of BA per se, but their
results for a similar intervention (motivational inter-
views) indicated that the cost per person improving
moderate PAwas between £2659 and £2789 and the
estimated cost per QALY was £47–£229. Boehler
et al15 estimated an incremental cost of £887 to
increase self-reported PA levels to 150 min of moder-
ate intensity activity per week (3 months postinter-
vention) when disease register screening was
compared with opportunistic patient recruitment.
Matrix5 estimated that BA compared with usual care
led to a cost per Quality Adjusted Life Years (QALY)
of £159 for advice by a family physician during con-
sultation and £425 for advice plus a booklet (mailed
2 weeks after).
There are a number of concerns about the rigour
of the evidence base that point to the need for
further evaluation. First, there is a signiﬁcant uncer-
tainty around the cost-effectiveness estimates partly
owing to notably weak effectiveness data. The
Open Access
Scan to access more
free content
Anokye NK, et al. Br J Sports Med 2014;48:202–206. doi:10.1136/bjsports-2013-092897 1 of 6
Original article
group.bmj.com on January 18, 2016 - Published by http://bjsm.bmj.com/Downloaded from 
effectiveness data were obtained from single studies that largely
had high attrition rates. In addition, parameter uncertainty was
inadequately explored with the studies mostly using determinis-
tic sensitivity analysis. Second, although the literature recognises
that individual’s PA behaviour is unstable, the economic models
have not explicitly accounted for this, but rather assumed con-
stancy of behaviour once people settle in the active state. This
approach potentially biases the estimated cost-effectiveness of
interventions.
This paper contributes to knowledge by addressing the limita-
tions in the current limited economic literature through the use
of the most up-to-date meta-analysed effectiveness data, and a
time-based modelling approach that accounts for variations in
PA behaviour.
METHODS
Modelling approach
A Markov model was developed to follow a cohort of physically
inactive but healthy adults over their remaining lifetime. The
starting age of the cohort (33 years) was chosen to reﬂect the
average age of participants in the trials of BA;11 however, results
were also estimated for cohorts of different ages in sensitivity
analysis. Figure 1 illustrates the model structure. The model was
run twice, once to estimate the cost and health effects with the
cohort being offered a BA (the intervention arm), and once fol-
lowing a usual care with no active intervention (the control arm).
For the intervention arm, BA was delivered at the start of the
ﬁrst model cycle (year 0). Then over an initial ‘run-in’ period of
1 year, members of the cohort either remained ‘inactive’ or
became ‘active’, with the proportion becoming active in each
arm reﬂecting the effectiveness evidence. The deﬁnition of activ-
ity used in the model was: undertaking a minimum of 150 min
of at least moderate intensive PA or at least 75 min of vigorous
intensive PA per week. This deﬁnition was chosen for consist-
ency with PA for health guidance, and the literature on the
effectiveness and risks for disease conditions.11 16–18 The run-in
period of 1 year was to allow the members of the cohort to
settle in more sustainable states of activity.
The model incorporated health beneﬁts from PA via reduced
risk for coronary heart disease (CHD), stroke and type 2 dia-
betes (T2D), as they have a high prevalence and PA interven-
tions exist which protect against these conditions. While many
other conditions are thought to be associated with PA, these
three conditions were chosen because there is relatively more
robust quantiﬁable evidence on the relationship between PA and
their incidence.19 Members of the cohort who were physically
active at the end of the run-in period were assumed to have a
better life expectancy and quality of life, due to lower risks of
developing CHD, stroke and T2D. However, the model
assumed that nobody would develop CHD, stroke or T2D
during the run-in period, although they could die from other
causes during this time. This was a conservative assumption, as
it introduced a delay in the onset of protective health beneﬁts
after people become physically active.
From the beginning of year 1 (cycle 2), each member of the
cohort had to be in one, and only one, of six health states: (1)
event free (no CHD, stroke, or T2D), (2) non-fatal CHD, (3)
non-fatal stroke, (4) T2D, (5) death related to CVD and (6)
death from non-CVD causes. Those who survived the run-in
period started in the event-free state (1), and then faced deﬁned
annual risks of moving to the other states. RRs for developing
CHD, stroke and T2D were estimated from epidemiological
studies, which measured baseline PA (exposure) and related this
to subsequent onset of CHD, stroke or T2D (outcomes) over a
Figure 1 Illustration of pathways within the model. CHD, coronary heart disease.
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deﬁned follow-up period (10 years). There is evidence that PA
habits can be quite changeable.20 Note that although changes in
PA after the run-in period were not explicitly modelled, the
impact of changing habits is incorporated in the cohort RR esti-
mates. The studies used16–18 followed up the same people (who
were either active or inactive at baseline) for a number of years,
during which some of the inactive people might have become
active or vice versa, diluting the observed relationships between
activity and outcomes.
The model assumed that a given proportion of CHD events and
of strokes would be immediately fatal. People who survived one of
these CVD events had an increased subsequent risk of CVD and
non-CVD mortality. Similarly, the onset of T2D increased CVD
and non-CVD mortality. For simplicity, individuals were assumed
to experience only one type of disease event (CHD, stroke or
T2D). The non-fatal CHD, non-fatal stroke and T2D health states
should therefore be regarded as containing mixed populations,
including patients with comorbidities and established disease as
well as incident cases with a single diagnosis.
Estimates of lifetime costs and QALYs were obtained from the
model by weighting the time spent by the cohort in the various
health states by the annual costs of treatment and utility values
associated with each state. The cost of delivering BA was also
added in the ﬁrst year for the intervention arm. In addition, indi-
viduals who became active in the ﬁrst year (in both arms) were
attributed a utility gain to reﬂect the short-term psychological
beneﬁts of PA.21 22 Economic evaluation of PA interventions, to
date, has hardly accounted for the short-term psychological bene-
ﬁts (ie, mental simulation during exercise, or improved social
interactions resulting from group participation)22 and rather has
focused on the long-term effects of sustained PA on the incidence
of chronic conditions. The details of the derivation of this utility
estimate are available from Pavey et al.22
The model adopted a healthcare (National Health Service,
England) perspective, applied discounting to treatment costs
and health outcomes at the rates of 3.5% per annum23 and
costs were adjusted using inﬂation indices.24 The costs are
expressed in £2010–2011 prices.
Model inputs
Online supplementary table S1 shows the data used to populate
the model. Data were obtained from a systematic literature
review and meta-analysis of clinical and economic evidence on
BA (for the effectiveness and cost of BA); economic evaluations
that were conducted for the existing NICE guidelines for CVD
and diabetes (for cost and utility estimates for disease condi-
tions) and the national/international guideline reports that set
out the science-based guidance on PA and health, for example,
the US Physical Activity Guidelines Advisory Committee
Report25 (for health impacts of PA). The clinical evidence (in
rates) was converted to probabilities following the approach in
Briggs et al26 as appropriate.
The RRs of CHD, stroke and T2D for physically active com-
pared with inactive people were based on cohorts that were fol-
lowed up for 19 (CHD, stroke) and 12 years (diabetes).16–18 As
noted earlier, these RRs accounted for variations in PA during
the follow-up periods. However, assuming that these estimates
would hold beyond the follow-up periods might be unrealistic.
It was therefore assumed, conservatively, that these RR estimates
held for an initial 10-year period, after which no beneﬁt would
persist, that is, the RRs for developing CHD, stroke and T2D in
the ﬁrst 10 years of the model were based on Hu et al,16–18 but
from year 11 onwards they were assumed to be equal to 1. This
assumption was tested in the sensitivity analysis.
The probabilities for developing the disease conditions used in
the model were derived using the following steps. First, the prob-
abilities of developing these conditions among inactive people
were estimated by adjusting the UK general population age-
speciﬁc incidence rates28–30 using the attributable risk fraction.34
To adjust these estimates appropriately, the second step estimated
the probability of developing the conditions among active indivi-
duals using the RR estimates identiﬁed from Hu et al.16–18
The probability that a primary stroke or CHD event was
fatal28 was assumed to be independent of PA. Although this is a
simpliﬁcation, as these probabilities could depend on the level
of PA, lack of data precluded adjusting for such a possibility.
To derive the probability of CVD-related (ie, CHD and
stroke) and non-CVD-related mortality, RRs of CVD-related
and non-CVD-related mortality27 28 among people with CHD,
stroke and T2D were used to adjust age-speciﬁc probabilities for
‘healthy people’. The age-speciﬁc probabilities were derived
using age-speciﬁc UK interim life tables from Government
Actuaries Department that were adjusted by age-speciﬁc UK
annual incidence of mortality prepared by the Ofﬁce of
National Statistics. The RR estimates for diabetic patients were
based on a cohort of Framingham Heart Study (aged 45–74)
that were followed for up to 25 years.28 For stroke patients,
data were obtained from Bronum-Hansen et al27 that followed a
cohort of 25+-year-olds for 10 years (after their ﬁrst non-fatal
stroke). These same data28 were applied to patients with CHD
due to data constraints.
Sensitivity analyses
Deterministic and probabilistic sensitivity analyses (PSA) were used
to explore the uncertainty around parameter estimates. One-way
deterministic sensitivity analysis was used to examine the uncer-
tainty around effectiveness parameter, health impacts of PA, the
starting age of cohort, the discount rate and costs. Changes in
starting age of cohort were to provide an indication of the impact
of exposing older people to BA. The variations in cost were to
demonstrate how differing recruitments to BA (ie, opportunistic vs
disease register) or staff changes affect the efﬁciency of BA given
that different deﬁnitions for BA can be provided by various types
of health professionals. The choice of parameter ranges reﬂected
alternative values from the literature and potential policy targets
that were noted in discussions with the NICE ofﬁcials.
Uncertainties around all parameters in the model (except
baseline mortality—from census data and national database that
are less likely to have errors) were addressed simultaneously
using PSA. The details of the distributions and data used in the
PSA are provided in table 1. A total of 10 000 Monte Carlo
simulations were used for the PSA to generate stable estimates.
Table 1 Base-case cost-effectiveness results comparing BA with
usual care
BA Usual care Incremental
Mean (95% interval*)
Costs
(lifetime)†
£155 m (140.5, 170.5) £154.2 m (138.7, 169.7) £806k (610, 998)
QALYs
(lifetime)
1.828 m (1.507, 2.186) 1.827 m (1.506, 2.185) 466 (101, 1109)
*Based on 10 000 Monte Carlo simulations.
†In 2011 prices; m=million, k=thousand.
BA, brief advice; QALYs, quality-adjusted life-years.
Anokye NK, et al. Br J Sports Med 2014;48:202–206. doi:10.1136/bjsports-2013-092897 3 of 6
Original article
group.bmj.com on January 18, 2016 - Published by http://bjsm.bmj.com/Downloaded from 
Model veriﬁcation and validation
Good practice guidance for veriﬁcation and validation35 36 was
followed. The computer model was reviewed and tested by
experienced modellers not connected to this study to ensure
that it behaved in accordance with the conceptual model. In
addition, the models were cross-validated with real-world obser-
vations. For example, model predictions of the incidence of car-
diovascular events were compared with observed event rates
from clinical trials (not used in the construction of the model).
RESULTS
Base case analysis
On the basis of a cohort of 100 000 people offered BA com-
pared with usual care, an estimated 6994 additional people
would become active (at the end of year one) at a total cost of
£950 000 (£136/additionally active person). BA also averted an
estimated 2.4 CHD, 1.8 stroke and 3.1 diabetes events, as well
as 1 death in 10 years. Table 1 shows that compared with usual
care, BA is more expensive as it is estimated to generate add-
itional costs of £806 809, but it is also more effective leading to
466 QALYs gained in the total cohort (mean QALY gain of
0.0047/person). The incremental cost effectiveness ratio (ICER)
for BA compared with usual care was £1730/QALY gained,
which can be considered cost-effective at a threshold of £2000/
QALY and well below the £20 000/QALY threshold as indicated
by the NICE public health reference case.23
Sensitivity analyses
Online supplementary table S3 indicates that variations in par-
ameter estimates largely resulted in some occasions ICERs that
were not ‘decisionally’ signiﬁcant according to the current
thresholds for cost-effectiveness in England. For example, plaus-
ible changes to the assumed effectiveness of BA led to ICER esti-
mates that remained well below the lower NICE threshold of
£20 000/QALY gained. The ICER was, however, sensitive to the
inclusion of short-term psychological beneﬁts associated with
PA. The longer the length and the higher the value of gain, the
lower the ICER is. Moving from 0.07 to 0.01 still resulted in an
ICER of less than £9000/QALY. However, excluding any short-
term psychological beneﬁts from exercise itself led to an ICER
of £27 000/QALY gained, which is of borderline cost-
effectiveness. Conversely, improved cost-effectiveness estimates
were observed for relatively older cohorts. For example, using a
start-up age of 54 years (and beyond) for the cohort resulted in
BA dominating usual care.
Whether the BA (compared with usual care) is considered
cost-effective depends on the maximum amount decision
makers are willing to spend to obtain an additional QALY. The
cost-effectiveness acceptability curve (see ﬁgure 2) based on
10 000 Monte Carlo simulations shows that at a threshold of
£2000/QALY there is an estimated 0.52 probability that BA is
cost-effective. This increases to 0.91 when a threshold of £5000
is considered and the probability further rises to about 0.99
given a threshold of £20 000.
DISCUSSION
This study evaluates the cost-effectiveness of BA using a Markov
modelling approach, and addresses key limitations in the litera-
ture regarding efﬁciency. The base case analysis resulted in an
estimated cost-effectiveness ratio of £1730/QALY gained from
BA compared with usual care. This is signiﬁcantly below the
usual cost-effectiveness threshold for England which ranges
from £20 000 to £30 000/QALY. The lifetime QALY gain per
person as a result of BA is estimated at approximately 0.005. If
each QALY gain is valued at £20 000 then BA could generate
beneﬁts that in monetary terms is about £93/person which
exceeds the cost of the intervention (£9.50/person). These ﬁnd-
ings are consistent with the existing limited literature of BA that
suggests that it is cost-effective at £20 000/QALY.
The base case results were generally robust to probabilistic and
deterministic sensitivity analysis with the latter showing that at
£20 000 threshold, there is a 99.9% chance that BA will be cost-
effective. The ICERs improve when the start-age of the cohort
increases or recruitment to BAwas changed from the opportunis-
tic centres to disease register. This suggests that the payoffs may
be higher if BA is targeted at older individuals (particularly
beyond 50 years as indicated in the deterministic sensitivity
analysis).
However, a number of uncertainties remain. As the ICER was
sensitive to inclusion and size of direct quality of life beneﬁts
(short-term psychological beneﬁts) of PA, it is essential to assess
the limitations of the evidence base related to these beneﬁts.
First, the analysis used an estimate based on cross-sectional data,
and as such a causal relationship between utility gains and PA
cannot be claimed. While participation in PA could lead to
mental health beneﬁts,21 concerns exist over whether the utility
estimate used in our study represents a mental health gain or
the long-term beneﬁts (reduced risk for ill-health conditions) of
PA. Nevertheless, as other disease conditions related to PA were
adjusted for in the analysis, the utility gain might be argued to
more closely approximate mental health beneﬁts.37 Also, sensi-
tivity analysis showed that assumptions around the magnitude
and duration of the mental health gains were not decisionally
important, as BA remained cost-effective at the upper threshold
value of £30 000/QALY when this beneﬁt was excluded.
Nevertheless, further evidence on mental health or ‘well-being’
beneﬁts of PA (estimated using, eg, longitudinal data) would still
be valuable.
The model accounted for the long-term impact of PA on
selected morbidities. However, there are other morbidities that
may be affected by PA that were excluded from the analysis.
Their exclusion might have underestimated the cost-
effectiveness of BA. Another possible bias may arise from our
omission of secondary transitions between the disease condi-
tions, which may have reduced the estimated negative effects of
physical inactivity. Conversely, the exclusion of adverse effects
of PA (eg, injuries) may have led to overestimated cost-
effectiveness. Although fear of injury could inﬂuence delivery of
BA or participation in PA, mostly in the elderly, the evidence
Figure 2 Cost-effectiveness acceptability curve showing the
probability of cost-effectiveness for brief advice at different threshold
levels.
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suggests such injuries might be rare38 and not likely to signiﬁ-
cantly affect the results at a population level.
This study uses previous research as a point of departure, and
builds on this through a number of improvements including: (1)
time-based modelling (2) more extensive exploration of uncer-
tainty around input parameters and assumptions, (3) more con-
servative assumptions around changes in PA over time that
underestimated beneﬁts of PA and (4) use of meta-analysed
effectiveness data. Although this study did not produce ‘deci-
sionally’ different results, there are a number of beneﬁts asso-
ciated with the new approach. First, it demonstrated that
assumptions around the maintenance of PA levels beyond BA
determine how cost-effective the intervention is. Second, short-
term mental health beneﬁt was found to be an important
outcome in modelling the cost-effectiveness of BA. Third, the
cost-effectiveness of BA was shown to vary by age, with
improved cost-effectiveness in older cohorts. Nevertheless, the
limitations of this analysis point to the need for new data and
for more accurate evidence on factors contributing to the cost-
effectiveness of BA to increase PA.
What is already known about this topic?
▸ Only 3 of 10 adults in England undertake a level of activity
that is sufﬁcient to meet the recommended levels of physical
activity (PA), as deﬁned by the department of health.
▸ Brief advice (BA) in primary care is considered as an
effective way of increasing physical activity among adults.
▸ There is little evidence on the cost-effectiveness of BA in
primary care and concerns exist about the rigour of the
limited evidence base.
What this study adds?
▸ This study builds on the current limited economic literature
through a number of improvements including: (1) time-based
modelling, (2) more extensive exploration of uncertainty
around input parameters and assumptions, (3) more
conservative assumptions around changes in PA over time
and (4) use of meta-analysed effectiveness data.
▸ BA in primary care, compared with usual care, is shown to
be a cost-effective way to improve physical activity among
adults.
▸ The cost-effectiveness of BA in primary care appears to vary
with the start-up age of individuals.
How might it impact on clinical practice in the near
future?
▸ Supports the provision of BA in primary care for physically
inactive people.
▸ Future delivery of BA in primary care might target older
adults (beyond 50 years) as it offers more value for money.
▸ Recruitment of individuals for BA in primary care might be
based on disease registers rather than opportunistic centres.
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